Interleukin-17 (IL-17) Inhibitor in Combination With Tumor Necrosis Factor α (TNFα )Inhibitor for the Treatment of Ankylosing Spondylitis
Clinical trial NCT06833112 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06833112
- Sponsor
- The Affiliated Hospital Of Guizhou Medical University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-01
- Primary completion
- 2027-08-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.